Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

286
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
286
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Harmonizing standards and resources for the medical genome.

Nature·2026
Same author

Laying the Foundation for Clinically Actionable Genomic Subtyping in Diffuse Large B-cell Lymphoma.

Blood cancer discovery·2026
Same author

Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Digging deep for the roots of lymphoma.

Blood·2026
Same author

Multidimensional Characterization of Tumor-Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes.

Cancer discovery·2026
Same author

Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

相关实验视频

Updated: Jun 7, 2025

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

10.9K

在血液性恶性瘤中,无细胞DNA.

Joseph G Schroers-Martin1, Ash A Alizadeh1,2,3

  • 1Department of Medicine, Divisions of Hematology & Oncology, Stanford University Medical Center, Stanford, CA.

JCO oncology practice
|November 12, 2024
PubMed
概括

无细胞DNA (cfDNA) 为监测淋巴瘤,骨髓瘤和白血病等血液癌症提供了一种非侵入性方法. 本综述探讨了cfDNA技术及其在血液恶性瘤中的临床应用.

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 分子诊断学 分子诊断学

背景情况:

  • 无细胞DNA (cfDNA) 分析是为固体瘤建立的.
  • 血液癌症的分子评估通常依赖于循环瘤细胞或骨髓活检.
  • cfDNA为血液性恶性瘤提供了一个新兴的,不那么侵入性的替代方案.

研究的目的:

  • 审查血液癌症中cfDNA分析的关键技术.
  • 讨论关于cfDNA在淋巴瘤,骨髓瘤和白血病中利用的当前临床数据.
  • 突出cfDNA在疾病评估中独立于侵入性程序的潜力.

主要方法:

  • 对血液恶性瘤中cfDNA的现有文献和临床研究的综述.
  • 对cfDNA检测和量化技术进步的分析.
  • 关于cfDNA在淋巴瘤,骨髓瘤和白血病中的应用的临床数据的综合.

主要成果:

  • cfDNA为血液癌症的疾病评估和监测提供了一个有前途的方法.
  • 对于cfDNA分析,关键技术正在出现,使瘤负担独立的量化成为可能.
  • 临床数据支持cfDNA在治疗淋巴瘤,骨髓瘤和白血病中的作用越来越大.

更多相关视频

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor
06:20

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor

Published on: January 12, 2024

1.9K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

13.9K

相关实验视频

Last Updated: Jun 7, 2025

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

10.9K
Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor
06:20

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor

Published on: January 12, 2024

1.9K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

13.9K

结论:

  • cfDNA是血液学中的新兴工具,补充了既有方法.
  • 非侵入性cfDNA分析对表征和监测血液癌症具有重大潜力.
  • 目前正在进行进一步的研究和验证,以将cfDNA纳入血液恶性瘤的常规临床实践.